Trial
NCT01746173
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
Massachusetts General Hospital; Beth Israel Deaconess Medical Center
Condition
T-cell Non-Hodgkin Lymphoma
Intervention
Cyclophosphamide
Why stopped
Slow accrual and futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-30